| Firm | Analyst | Phone | Type | Rating | |
|---|---|---|---|---|---|
|
BOFA SECURITIES
|
Tazeen Ahmad | ||||
|
B. RILEY SECURITIES
|
Mayank Mamtani | ||||
|
BTIG
|
Thomas Shrader, PhD | ||||
|
CANTOR FITZGERALD
|
Josh Schimmer, MD | ||||
|
COWEN
|
Joseph Thome, Ph.D. | ||||
|
Deutsche Bank
|
David Hoang, MD, Ph.D. | ||||
|
EVERCORE ISI
|
Michael DiFiore, Pharm.D. | ||||
|
GOLDMAN SACHS
|
Salveen Richter | ||||
|
H.C. WAINWRIGHT
|
Andrew Fein | ||||
|
JEFFERIES
|
Andrew Tsai | ||||
|
J.P. MORGAN
|
Jessica Fye | ||||
|
LEERINK PARTNERS
|
Marc Goodman | ||||
|
MORGAN STANLEY
|
Sean Laaman | ||||
|
OPPENHEIMER
|
Jay Olson, CFA | ||||
|
ROBERT W. BAIRD & CO.
|
Charlie Moore | ||||
|
STIFEL
|
Paul Matteis | ||||
|
UBS
|
Michael Yee | ||||
|
WEDBUSH SECURITIES
|
Laura Chico, PhD | ||||
|
WILLIAM BLAIR
|
Myles Minter, Ph.D. | ||||
|
WOLFE RESEARCH
|
Rudy Li, Ph.D |
Denali Therapeutics is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding Denali Therapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Denali Therapeutics or its management. Denali Therapeutics does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.